KEAP1-mutations and NFE2L2-mutations in patients with non-small cell lung cancer (NSCLC)

被引:0
作者
Frank, R. [1 ]
Scheffler, M. [1 ]
Michels, S. [1 ]
Eisert, A. [1 ]
Fischer, R. [1 ]
Koenig, K. [2 ]
Merkelbach-Bruse, S. [3 ]
Serke, M. [4 ]
Ko, Y. D. [5 ]
Gerigk, U. [6 ]
Geist, T. [7 ]
Heukamp, L. [3 ]
Buettner, R. [3 ]
Wolf, J. [1 ]
机构
[1] Uniklin Koln, Dept Internal Med 1, LCGC, Cologne, Germany
[2] Uniklin Koln, Dept Pathol, Cologne, Germany
[3] Uniklin Koln, Inst Pathol, Cologne, Germany
[4] Lungenklin Hemer, Lungcanc, Hemer, Germany
[5] Johanniter Krankenhaus Bonn, Oncol, Bonn, Germany
[6] Evangel Kliniken Johanniter & Waldkrankenhaus Bon, Thoraxchirurg, Bonn, Germany
[7] Kaiserswerther Diakonie, Klin Pneumol Allergol Schlaf & Beatmungsmed, Pneumol, Dusseldorf, Germany
关键词
D O I
10.1016/S0959-8049(16)31766-X
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
3125
引用
收藏
页码:S645 / S645
页数:1
相关论文
共 50 条
[31]   KEAP1/NRF2 (NFE2L2) mutations in NSCLC-Fuel for a superresistant phenotype? [J].
Dempke, Wolfram C. M. ;
Reck, Martin .
LUNG CANCER, 2021, 159 :10-17
[32]   Association of germline mutations in EGFR and ABCG2 with gefitinib response in patients with non-small cell lung cancer (NSCLC). [J].
Gregorc, V ;
Cusatis, G ;
Spreafico, A ;
Amoroso, MG ;
Gianmarco, A ;
Ingersoll, RG ;
Sparreboom, A ;
Villa, E ;
Hidalgo, M ;
Baker, SD .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) :197S-197S
[33]   DDR2 mutations in non-small cell lung cancer (NSCLC): clinical, histological and genetic characteristics [J].
Scheffler, M. ;
Michels, S. ;
Gardizi, M. ;
Koenig, K. ;
Merkelbach-Bruse, S. ;
Stamm, K. ;
Heukamp, L. C. ;
Buettner, R. ;
Wolf, J. .
ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 :66-66
[34]   Infrequent ERBB2 mutations in Chinese patients with non-small cell lung cancer [J].
Feng, Shuidong ;
Ling, Hongyan ;
Guo, Hui ;
Tong, Lingling ;
Hu, Guobin ;
Liao, Li ;
Lv, Xueying ;
Tan, Hongzhuan ;
Wu, Yimou .
JOURNAL OF THORACIC DISEASE, 2014, 6 (05) :503-506
[35]   Integrated analysis of patients with KEAP1/NFE2L2/CUL3 mutations in lung adenocarcinomas [J].
Jin, Xing ;
Zheng, Yuansheng ;
Chen, Zhencong ;
Wang, Fei ;
Bi, Guoshu ;
Li, Ming ;
Liang, Jiaqi ;
Sui, Qihai ;
Bian, Yunyi ;
Hu, Zhengyang ;
Qiao, Yulei ;
Xu, Songtao .
CANCER MEDICINE, 2021, 10 (23) :8673-8692
[36]   Imaging mutations in non small cell lung cancer (NSCLC) [J].
Haslop, Anna ;
Robins, Edward George ;
Goggi, Julian Luke .
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2017, 60 :S337-S337
[37]   PD-L1 expression, EGFR mutations (EGFRm) and KRAS mutations (KRASm) in stage III unresectable non-small cell lung cancer (NSCLC) patients [J].
Cronin-Fenton, Deirdre ;
Dalvi, Tapashi ;
Hedgeman, Elizabeth ;
Norgaard, Mette ;
Pedersen, Lars ;
Hansen, Hanh ;
Fryzek, Jon ;
Walker, Jill ;
Mellemgaard, Anders ;
Rasmussen, Torben R. ;
Shire, Norah ;
Rigas, James ;
Potter, Danielle ;
Hamilton-Dutoit, Stephen ;
Sorensen, Henrik T. .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 :384-385
[38]   KEAP1/NFE2L2 Pathway Signature Outperforms KEAP1/NFE2L2 Mutation Status and Reveals Alternative Pathway-Activating Mutations in NSCLC [J].
Arolt, Christoph ;
Dugan, Margaret ;
Wild, Robert ;
Richartz, Vanessa ;
Holz, Barbara ;
Scheel, Andreas H. ;
Braegelmann, Johannes ;
Wagener-Ryczek, Svenja ;
Merkelbach-Bruse, Sabine ;
Wolf, Juergen ;
Buettner, Reinhard ;
Catanzariti, Luigi ;
Fler, Matthias Schef ;
Hillmer, Axel M. .
JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) :1550-1567
[39]   Detection of CDKN2A Gene Mutations in Patients with Non-Small Cell Lung Cancer Patients [J].
Wang, S. ;
Xu, C. ;
Wang, W. ;
Zhuang, W. ;
Song, Z. ;
Zhu, Y. ;
Chen, R. ;
Guan, Y. ;
Yi, X. ;
Chen, Y. ;
Chen, G. ;
Fang, M. ;
Lv, T. ;
Song, Y. .
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) :S1941-S1941
[40]   Prognostic significance and origin of plasma KRAS mutations in patients with non-small cell lung cancer (NSCLC) [J].
Gautschi, Oliver ;
Ziegler, Annemarie ;
Huegli, Barbara ;
Gugger, Mathias ;
Ratschiller, Daniel ;
Mack, Philip C. ;
Kung, Hsing-Jien ;
Stahel, Rolf A. ;
Gandara, David R. ;
Betticher, Daniel C. .
JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) :S443-S443